Skip to content
Screener

Artivion AORT Total Liabilities & Equity

Total Liabilities & Equity at other companies

Abbott logo
AbbottABT
$109.22B+30.0%
Edwards Lifesciences logo
Edwards LifesciencesEW
$13.32B+2.3%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$640.55M+10.9%
Medtronic logo
MedtronicMDT
$93.03B+1.5%
ITG
Integer HoldingsITGR
$3.41B+3.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.72B+10.2%

Other financials

Income statement

See full
Revenue$125.8M+11.3%
Gross profit$80.5M+10.1%
Operating income-$8.4M-200%
Net income-$13.5M-1,104%
EPS (diluted)-$0.28-1,033%

Balance sheet

See full
Cash & equivalents$77.3M+44.6%
Total debt$408.0M+54.7%
Total equity$445.6M+6.1%
Total assets$1.1B+27.9%

Cash flow

See full
Operating cash flow-$1.3M-108%
CapEx$10.7M+227%
Free cash flow-$12.0M

Valuation

See full
Market cap$1.32B-31.8%
Enterprise value$1.65B-23.0%
P/S2.8×-2.0×

Profitability

See full
Gross margin64.4%+0.4pp
Operating margin4.4%0.0pp
Net margin-0.7%-0.3pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity-0.7%-0.3pp
Debt / equity0.9×+0.3×
Current ratio3.5×-1.3×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Artivion’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 1:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054746
Line itemJune 30,2026December 31,2025
Preferred stock $0.01 par value per share, 5,000 shares authorized, no shares issued
Common stock $0.01 par value per share, 75,000 shares authorized, 50,179 and 49,330 shares issued as of June 30, 2026 and December 31, 2025, respectively502493
Additional paid-in capital535,798516,604
Retained deficit(63,591)(51,498)
Accumulated other comprehensive loss(12,476)(2,719)
Treasury stock, at cost, 1,487 shares as of June 30, 2026 and December 31, 2025(14,648)(14,648)
Total stockholders’ equity445,585448,232
Total liabilities and stockholders’ equity$1,071,934$884,796

Item 1. Financial Statements.

FAQ

What is Artivion's total liabilities & equity?
Artivion (AORT) reported total liabilities & equity of $1.07B in Q2 2026.
How has Artivion's total liabilities & equity changed year-over-year?
Artivion's total liabilities & equity increased by 27.9% year-over-year, from $838.39M to $1.07B.
What is the long-term trend for Artivion's total liabilities & equity?
Over 5 years (2020 to 2025), Artivion's total liabilities & equity has grown at a 2.3% compound annual growth rate (CAGR), from $789.4M to $884.8M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Artivion's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude